Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Breidenbach

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta. Proteins and Proteomics|May 15, 2020
Coumarin as a structural component of substrates and probes for serine and cysteine proteasesJulian Breidenbach, Ulrike Bartz, Michael Gütschow
Archiv Der Pharmazie|December 23, 2025
Sequential Optimization Approach Toward an Azapeptide-Based SARS-CoV-2 Main Protease InhibitorRabea Voget, Victoria Steiger, Julian Breidenbach, et al.
International Journal of Molecular Sciences|February 25, 2023
Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease InhibitorsNina Geiger, Viktoria Diesendorf, Valeria Roll, et al.
Acta Pharmaceutica Sinica. B|May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kineticsRabea Voget, Julian Breidenbach, Tobias Claff, et al.
Journal of Medicinal Chemistry|May 16, 2024
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral DrugsJulian Breidenbach, Rabea Voget, Yaoyao Si, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2021
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored InhibitorsJulian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, et al.
ACS Pharmacology & Translational Science|April 18, 2024
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity"Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological ActivityPhilipp Flury, Julian Breidenbach, Nadine Krüger, et al.
Journal of Medicinal Chemistry|January 15, 2025
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral ActivityPhilipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Proteins and Proteomics|May 15, 2020
Coumarin as a structural component of substrates and probes for serine and cysteine proteasesJulian Breidenbach, Ulrike Bartz, Michael Gütschow
Archiv Der Pharmazie|December 23, 2025
Sequential Optimization Approach Toward an Azapeptide-Based SARS-CoV-2 Main Protease InhibitorRabea Voget, Victoria Steiger, Julian Breidenbach, et al.
International Journal of Molecular Sciences|February 25, 2023
Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease InhibitorsNina Geiger, Viktoria Diesendorf, Valeria Roll, et al.
Acta Pharmaceutica Sinica. B|May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kineticsRabea Voget, Julian Breidenbach, Tobias Claff, et al.
Journal of Medicinal Chemistry|May 16, 2024
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral DrugsJulian Breidenbach, Rabea Voget, Yaoyao Si, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2021
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored InhibitorsJulian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, et al.
ACS Pharmacology & Translational Science|April 18, 2024
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity"Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological ActivityPhilipp Flury, Julian Breidenbach, Nadine Krüger, et al.
Journal of Medicinal Chemistry|January 15, 2025
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral ActivityPhilipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Pageof 1